查詢結果分析
相關文獻
- Monitoring the Antimicrobial Resistance of Pathogenic Fungus and Verification of the Antifungal Susceptibility Test
- Perinatal Candidiasis and Transient Maternal Candidemia: Report of One Case
- Isolated Candida Arthritis of the Knee: Report of One Case and Review of the Literature
- 全人工膝關節置換術後之黴菌感染:一例報告
- 念珠菌感染(Candidiasis)
- Factors Accounting for Misidentification of Candida Species
- Acute Suprarenal Aortic Occlusion Caused by Fungal Endocarditis: A Case Report
- 低頻切位聚合酶鏈鎖反應在三種Candida Species分子生物分型上的應用
- Molecular Epidemiology of Candida Colonizing Critically Ill Patients in Intensive Care Units
- Candida Vertebral Osteomyelitis: A Case Report and Review of the Literature
頁籤選單縮合
題 名 | Monitoring the Antimicrobial Resistance of Pathogenic Fungus and Verification of the Antifungal Susceptibility Test=真菌病原抗藥性監測暨真菌藥敏試驗方法評估計畫 |
---|---|
作 者 | 楊玉英; 葉瑞忠; 謝玉芬; 黃勝敏; 黃梅; | 書刊名 | 秀傳醫學雜誌 |
卷 期 | 14:3/4 2015.12[民104.12] |
頁 次 | 頁75-84 |
分類號 | 414.83 |
關鍵詞 | 抗真菌藥敏試驗; 念珠菌; 真菌藥敏測試盤; 酵母菌藥物敏感性試驗套組第三代; Antifungal susceptibility test; Candida; YeastOne; ATB Fungus 3; |
語 文 | 英文(English) |
中文摘要 | 近年來由於廣效性抗微生物製劑的大量使用及免疫低下病患族群的增加,使得 伺機性病原如酵母菌的感染增加。念珠菌(Candida spp.)在國內外均已是造成醫療 照護相關血流感染的主要病原,使得抗真菌藥物抗藥性的控制更受重視。念珠菌對 不同抗真菌藥物具有不同的感受程度,且存在地區性及時間性的差異。本計畫主要 目的為進行本院念珠菌臨床分離株的藥物敏感性試驗,藉此建立不同菌種抗藥性資 料庫,以提供臨床醫師用藥參考,並監測本院真菌抗藥性狀況。結果顯示針對98 隻臨床念珠菌分離株當中,C. albicans 對所測試的抗真菌藥物皆呈現susceptible , 而C. glabrata 及C. tropicalis 對azoles 藥物的抗藥性比例都較C. albicans 高,且對於 不同種類的azoles 類藥物其感受性程度也較不一致。此外,本次研究也針對兩種市 售抗真菌藥敏系統:Sensititre YeastOne(Trek Diagnostic Systems)及ATB Fungus 3(bioMérieux Clinical Diagnostics)比較兩者之表現。YeastOne 測試組完整提供目 前臨床常用九種抗真菌藥物藥敏結果,操作方便且可提供更客觀判讀方式,其應用 性也優於ATB Fungus 3,更適合用於臨床實驗室。 |
英文摘要 | Because of the abuse of extended antimicrobial agents and the increasing number of immunocompromised patients, infections caused by opportunistic pathogens, such as yeast, have increased significantly. As Candida species have become a prominent cause of nosocomial bloodstream infections, the emergence of antifungal resistance has become an important public health problem. Since antifungal susceptibilities may differ in different geographical areas and over time, surveillance reports for detection of resistance patterns are encouraged. The aim of this study was to test the antifungal susceptibilities of clinical Candida isolates, understand the resistance pattern of these pathogens and establish a database of antifungal susceptibilities to offer clinicians choices for empirical treatment when fungal infection is suspected. Our results indicate that C. albicans are susceptible to all the tested antifungal drugs. C. glabrara and C. tropicalis are more resistant to these antifungal agents than C. albicans and have different susceptibility patterns among fluconazole, itraconazole, and voriconazole. In addition, we evaluated the performance of two commercial systems, Sensititre YeastOne (Trek Diagnostic Systems) and ATB Fungus 3 (bioMérieux Clinical Diagnostics). YeastOne can provide an easy set-up procedure and reliable endpoint determinations. It is potentially useful for antifungal susceptibility testing of yeasts in clinical laboratories. |
本系統中英文摘要資訊取自各篇刊載內容。